Nucleotide sugar

Source: Wikipedia, the free encyclopedia.

Nucleotide sugars are the activated forms of

monosaccharides. Nucleotide sugars act as glycosyl donors in glycosylation reactions. Those reactions are catalyzed by a group of enzymes called glycosyltransferases
.

History

The anabolism of oligosaccharides - and, hence, the role of nucleotide sugars - was not clear until the 1950s when

Leloir and his coworkers found that the key enzymes in this process are the glycosyltransferases. These enzymes transfer a glycosyl group from a sugar nucleotide to an acceptor.[1]

Biological importance and energetics

To act as glycosyl donors, those monosaccharides should exist in a highly energetic form. This occurs as a result of a reaction between nucleoside triphosphate (NTP) and glycosyl monophosphate (phosphate at

anomeric carbon). The recent discovery of the reversibility of many glycosyltransferase-catalyzed reactions calls into question the designation of sugar nucleotides as 'activated' donors.[2][3][4][5][6]

Activation of Monosaccharides
Activation of Monosaccharides

Types

There are nine sugar nucleotides in humans which act as glycosyl donors and they can be classified depending on the type of the nucleoside forming them:[7]

In other forms of life many other sugars are used and various donors are utilized for them. All five of the common nucleosides are used as a base for a nucleotide sugar donor somewhere in nature. As examples,

TDP-glucose give rise to various other forms of CDP and TDP-sugar donor nucleotides.[9][10]

Structures

Listed below are the structures of some nucleotide sugars (one example from each type).

UDP-Gal CMP-NeuNAc GDP-Man
UDP-Gal CMP-Neu5Ac
GDP-Man

Relationship to disease

Normal metabolism of nucleotide sugars is very important. Any malfunction in any contributing enzyme will lead to a certain disease [11] for example:

  1. Inclusion body myopathy: is a congenital disease resulted from altered function of UDP-GlcNAc epimerase .
  2. Macular corneal dystrophy: is a congenital disease resulted from malfunction of GlcNAc-6-sulfotransferase.
  3. Congenital disorder in α-1,3 mannosyl transferase will result in a variety of clinical symptoms, e.g. hypotonia, psychomotor retardation, liver fibrosis and various feeding problems.

Relationship to drug discovery

The development of chemoenzymatic strategies to generate large libraries of non-native sugar nucleotides has enabled a process referred to as

pharmaceuticals and complex natural product-based leads.[12][13]

See also

References

  1. .
  2. .
  3. .
  4. .
  5. .
  6. .
  7. ^ Cold Spring Harbor Laboratory Press Archived 2011-07-08 at the Wayback Machine Essentials of Glycobiology, Second Edition
  8. PMID 27194101
    .
  9. .
  10. .
  11. ^ Encyclopedia of Biological Chemistry, Volume 2. 2004, Elsevier Inc. Hudson H. Freeze 302-307.
  12. PMID 16309329
    .
  13. .

External links